Category
Category: Gene & Cell therapy
T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors
Why a US Presence Can Help European Biotechs Get Ahead
Record Funding for Gene and Cell Therapy Accompanies Turbulent Times
Covid-19 Forces Gene Therapy Companies to Shift Strategy
Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal
The Three Obstacles Stopping Cell Therapy Becoming Mainstream
Hansa Biopharma Gets up to €350M to Make Gene Therapy Work in Resistant Patients
CRISPR Therapeutics Announces Huge €400M Public Fundraise
Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy
CSL Behring Nabs UniQure’s Hemophilia Gene Therapy for up to €1.8B
